K-Ras Plasma Membrane Interactions: A Tractable Therapeutic Target |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.9, No. 5)Publication Date: 2020-07-15
Authors : Karen M Henkels; Kwang-jin Cho;
Page : 414-417
Keywords : Proteins; Mislocalize; Apoptosis; Components; Pharmacological;
Abstract
Ras proteins are small GTPases that function like a molecular switch regulating cell proliferation, survival and differentiation at the plasma membrane (PM). Of the three major Ras isoforms, constitutively active mutations in K-Ras are frequently found in human cancers. Despite its critical role in tumorigenesis, no anti-K-Ras therapies are currently available in clinic. One strategy for blocking oncogenic K-Ras activity is to disrupt K-Ras interaction with the PM since K-Ras must primarily interact with the PM for its biological activity. This review will provide insights into recently reported molecular mechanisms that regulate K-Ras from the PM, which can be targeted to disrupt oncogenic K-Ras signaling.
Other Latest Articles
- THE WISDOM OF SULTAN ZAINAL ABIDIN III IN DEALING WITH BRITISH INTERFERENCE IN TERENGGANU AFTER THE 1909 BANGKOK TREATY
- MULTI-DRUG RESISTANCE, THE MANMADE DISASTER
- ANTIPROLIFERATIVE POTENTIAL OF ESCITALOPRAM IN DIMETHYLHYDRAZINE (DMH) INDUCED COLON CANCER IN SWISS ALBINO MICE
- DEFAMILIARIZATION IN GLASS
- DYSPLASIE ARYTHMOGENE DE VENTRICULE DROIT REVELEE PAR UNE TACHYCARDIE VENTRICULAIRE CHEZ UN SUJET JEUNE
Last modified: 2023-06-20 21:31:14